Consumer |Hims
Hims Expands Testosterone Care with Injectable and Oral TRT, Its Largest Men’s Health Launch to Date
October 21, 2026 · 8:20 AM · SAN FRANCISCO
Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new injectable and oral testosterone replacement therapies (TRT) for eligible men. It’s the largest expansion of the company’s men’s health program since first introducing the category last September, giving eligible men more options to treat low testosterone in partnership with licensed providers through Hims. An estimated 20 million men1,2 i...
- PublishedOctober 21, 2026 · 8:20 AM
- LocationSAN FRANCISCO
- IndustryConsumer
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →